TREACE JAMES T 4
4 · TREACE MEDICAL CONCEPTS, INC. · Filed May 13, 2024
Insider Transaction Report
Form 4
TREACE JAMES T
Director
Transactions
- Purchase
Common Stock
2024-05-10$4.53/sh+83,000$376,023→ 894,441 total - Purchase
Common Stock
2024-05-13$4.54/sh+145,000$657,981→ 1,039,441 total
Holdings
- 556,183(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3300 to $4.7600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3800 to $4.6400 0inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.